Acromegaly
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Part I of the study: 1.Patients diagnosed as acromegaly during January 1, 2011 to December 31, 2020; 2.Both male and female, regardless of age. Part II of the study: Inclusion Criteria: 1.Patients are able and willing to sign informed consent (ICF); 2.Male, female, aged 18 to 75 years (including 18 years old and 75 years old); 3.Compliance with acromegaly diagnostic criteria: (1)At least one laboratory or medical record shows that the patient is random GH >= 2.5 µg/L; (2)At least one checklist or medical record shows radiographic evidence that the patient has a pituitary tumor.
Exclusion criteria
Exclusion criteria: Part I of the study: 1.Medical records showed that the patient had been diagnosed with other concurrent malignancies or had previously been diagnosed with another malignancy and had current evidence of residual lesions. Part II of the study: 1.Ectopic GH secretion or pituitary cancer; 2.The patient is diagnosed with other complicated malignancies, or has previously been diagnosed with another malignancy, and there is currently evidence of lesion residue; 3.The patient is diagnosed with a severe acute or chronic physical or mental illness that may increase the risk associated with study participation or may interfere with the interpretation of study results, as well as any outcome that, in the investigator's judgment, makes the patient ineligible for study enrollment; 4.In the judgment of the investigator, the patient was not eligible for inclusion in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical outcome;overall survival; | — |
Countries
China
Contacts
The First Affiliated Hospital of Ji'nan University